HomeEXECUTIVESCPR-T Hires Dave Gaddy as their Chief Engineering Officer

CPR-T Hires Dave Gaddy as their Chief Engineering Officer

CPR Therapeutics Inc. (CPR-T), an early-stage medtech startup company funded by the N.I.H and N.S.F to develop the next generation technology for cardiopulmonary resuscitation, announced today that Dave Gaddy has joined the Company as its first Chief Engineering Officer.

CPR Therapeutics is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is the leading cause of death in western countries and there are currently no devices more effective than manual chest compressions. Intact survival after sudden cardiac arrest is below 10% in most communities.

Norman Paradis MD, CPR Therapeutic’s Founder and CEO said “We are tremendously excited to have Dave’s expertise. His background in engineering and biomedical device development are a perfect fit for our technical and regulatory challenges. Our chances of success increase significantly with him as a member of our team.”

Asked to share his perspective on CPR Therapeutics Inc. and his new position, Dave Gaddy responded “Although I have had the opportunity to develop a number of innovative medical devices at my previous positions, I have always wanted to be part of the initial leadership team at an early-stage company taking on a major problem with a potentially impactful new technology. CPR Therapeutics Inc. gives me just that opportunity and then some.”

Dr. Paradis went on: “Dave’s first priority will be our NIH-NSF testbed which we will use to elucidate the optimal pattern of multimodal CPR. And almost immediately, he will start project development for our first clinical device, a cathlab version of our core vest technology for early FDA 510K clearance.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.

By using this website you agree to accept Medical Device News Magazine Privacy Policy